Search Results 551-560 of 16992 for monoclonal antibody
Although the prognosis for such patients is generally poor, the use of humanized monoclonal anti-HER2 antibodies, such as trastuzumab, has resulted in long ...
we have or monoclonal antibodies? ... Halena Gazelka 10:23. Greg, is it known yet if that antiviral would be used in conjunction with monoclonal antibody, for ...
Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving dendritic cell therapy, cryosurgery and ...
The development of trastuzumab in the early 2000s as an antibody-based targeted therapeutic for HER2+ breast cancer heralded a new era of precision medicine in ...
... antibody can't bind to it or binds less tightly. ... Badley, could reduce or nullify beneficial effects of therapies that rely heavily on antibodies: monoclonal ...
... monoclonal antibody treatments than any other health care organization, demonstrating a significant decrease in hospitalization rates and mortality.
... antibody therapy, such as trastuzumab emtansine (T-DM1) and/or pertuzumab ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ...
... monoclonal gammopathy of undetermined significance and implications for recategorizing disease entities, which will be published in the October 2010 issue ...
The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myleoma (MM) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.